This report is being submitted retrospectively as part of internal review.A review of the device's manufacturing records revealed that the sensor lot met all requirements including sterilization requirements for release.The sensor is inserted by making a small incision and placing it under skin and potential for developing skin irritation/swelling/pain/ inflammation/infection around the insertion site is a known anticipated adverse event.No further investigation was necessary for this complaint.Due to the symptoms experienced by the patient, the sensor was removed by the physician.Patient reported that he had similar issues with other implantable devices and presume that his body do not adapt to those.Patient also mentioned that the symptoms are not attributable to eversense xl cgm system and would undergo further tests and then decide to get reinserted with another eversense sensor.
|